BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10417424)

  • 1. [PTEN: a tumor suppressor with original properties].
    Roux P
    Bull Cancer; 1999 Jun; 86(6):522-5. PubMed ID: 10417424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN: life as a tumor suppressor.
    Simpson L; Parsons R
    Exp Cell Res; 2001 Mar; 264(1):29-41. PubMed ID: 11237521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells.
    Lu Y; Lin YZ; LaPushin R; Cuevas B; Fang X; Yu SX; Davies MA; Khan H; Furui T; Mao M; Zinner R; Hung MC; Steck P; Siminovitch K; Mills GB
    Oncogene; 1999 Nov; 18(50):7034-45. PubMed ID: 10597304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.
    Ramaswamy S; Nakamura N; Vazquez F; Batt DB; Perera S; Roberts TM; Sellers WR
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2110-5. PubMed ID: 10051603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
    Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
    Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PTEN tumor suppressor: functions as a lipid phosphatase].
    Maehama T; Dixon JE
    Tanpakushitsu Kakusan Koso; 2000 Oct; 45(14):2405-14. PubMed ID: 11051842
    [No Abstract]   [Full Text] [Related]  

  • 7. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
    Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
    Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo.
    Saito Y; Swanson X; Mhashilkar AM; Oida Y; Schrock R; Branch CD; Chada S; Zumstein L; Ramesh R
    Gene Ther; 2003 Nov; 10(23):1961-9. PubMed ID: 14528320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN and myotubularin: novel phosphoinositide phosphatases.
    Maehama T; Taylor GS; Dixon JE
    Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN gene and integrin signaling in cancer.
    Tamura M; Gu J; Tran H; Yamada KM
    J Natl Cancer Inst; 1999 Nov; 91(21):1820-8. PubMed ID: 10547389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lipid phosphatase activity of PTEN is critical for its tumor supressor function.
    Myers MP; Pass I; Batty IH; Van der Kaay J; Stolarov JP; Hemmings BA; Wigler MH; Downes CP; Tonks NK
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13513-8. PubMed ID: 9811831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells.
    Tanaka M; Koul D; Davies MA; Liebert M; Steck PA; Grossman HB
    Oncogene; 2000 Nov; 19(47):5406-12. PubMed ID: 11103942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas.
    Tamura M; Gu J; Takino T; Yamada KM
    Cancer Res; 1999 Jan; 59(2):442-9. PubMed ID: 9927060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.
    Li J; Simpson L; Takahashi M; Miliaresis C; Myers MP; Tonks N; Parsons R
    Cancer Res; 1998 Dec; 58(24):5667-72. PubMed ID: 9865719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.
    Unoki M; Nakamura Y
    Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity.
    Hlobilkova A; Guldberg P; Thullberg M; Zeuthen J; Lukas J; Bartek J
    Exp Cell Res; 2000 May; 256(2):571-7. PubMed ID: 10772829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells.
    Furnari FB; Huang HJ; Cavenee WK
    Cancer Res; 1998 Nov; 58(22):5002-8. PubMed ID: 9823298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model.
    Weng LP; Brown JL; Eng C
    Hum Mol Genet; 2001 Mar; 10(6):599-604. PubMed ID: 11230179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN.
    Tamura M; Gu J; Matsumoto K; Aota S; Parsons R; Yamada KM
    Science; 1998 Jun; 280(5369):1614-7. PubMed ID: 9616126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN.
    Matsushima-Nishiu M; Unoki M; Ono K; Tsunoda T; Minaguchi T; Kuramoto H; Nishida M; Satoh T; Tanaka T; Nakamura Y
    Cancer Res; 2001 May; 61(9):3741-9. PubMed ID: 11325847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.